Prescription psychostimulants as a harm reduction and treatment intervention for methamphetamine use disorder and the implications for nursing clinical practice: A scoping review of the literature
International Journal of Mental Health Nursing · 2023
DOI: 10.1111/inm.13144 ↗Kurz gefasst
Scoping Review in der Zeitschrift International Journal of Mental Health Nursing, 2023. Verfasst von Don Leidl und 2 weiteren Autor:innen. Beteiligte Einrichtung: College of Nursing, University of Saskatchewan, Saskatoon, Canada. Hauptthemen laut MEDLINE: Methamphetamine, Central Nervous System Stimulants, Amphetamine-Related Disorders. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 94 Literaturangaben.
Abstract (Originalsprache)
The global rise in methamphetamine use and its negative effects warrants the need for research exploring harm reduction and treatment interventions for individuals with methamphetamine use disorder. Agonist medications have been utilized for years for the treatment of heroin and opioid addiction, but have yet to be incorporated into mainstream Canadian practice for methamphetamine dependence. This review aims to provide an overview of the current trends of prescription psychostimulant usage for individuals with methamphetamine use disorder from a Canadian perspective, identifies the barriers to accessing prescription psychostimulants for methamphetamine use disorder and highlights the nursing clinical practice implications in caring for individuals with the disorder. Discourse on the sustained abstinence and harm reduction debate is presented from the perspective of methamphetamine abuse is provided along with the neuropsychiatric complications of chronic methamphetamine use. The impacts of specific prescription psychostimulants on cognition are discussed as is the use of neuroimaging techniques to assess neuronal damage in methamphetamine users. Sign of toxicity, overdose and the contraindications for use of these prescription psychostimulants is also presented. The implications to nursing clinical practice in caring for this population is provided, touching on the clinical presentation of methamphetamine use, completing thorough assessment and screening and patient education. The findings of this review indicate the need for further research in this area exploring the benefits of prescription psychostimulants as a harm reduction and treatment intervention for the global problem of methamphetamine dependence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Nursing, University of Saskatchewan, Saskatoon, Canada.
Zitieren
APA
Leidl, D., Takhar, P., & Li, H. (2023). Prescription psychostimulants as a harm reduction and treatment intervention for methamphetamine use disorder and the implications for nursing clinical practice: A scoping review of the literature. International Journal of Mental Health Nursing. https://doi.org/10.1111/inm.13144
Vancouver
Leidl D, Takhar P, Li H. Prescription psychostimulants as a harm reduction and treatment intervention for methamphetamine use disorder and the implications for nursing clinical practice: A scoping review of the literature. International Journal of Mental Health Nursing. 2023. doi:10.1111/inm.13144
BibTeX
@article{Leidl2023,
author = {Leidl, Don and Takhar, Pearl and Li, Hua},
title = {Prescription psychostimulants as a harm reduction and treatment intervention for methamphetamine use disorder and the implications for nursing clinical practice: A scoping review of the literature},
journal = {International Journal of Mental Health Nursing},
year = {2023},
doi = {10.1111/inm.13144}
}
EUVIMED